Connecting you to content on EBSCOhost

Works by Bilal, Muhammad Sajjad

Results: 6

1

Benzene-1,3-diol derivatives as the inhibitors of butyrylcholinesterase: An emergent target of Alzheimer's disease.

Published in:

Journal of the Serbian Chemical Society, 2022, v. 87, n. 3, p. 293, doi. 10.2298/JSC210416073D

By:

YIN DONGLIANG;
EJAZ, SYEDA ABIDA;
AZIZ, MUBASHIR;
SAEED, AMNA;
EJAZ, SAMINA;
BILAL, MUHAMMAD SAJJAD;
MAHMOOD, HAFIZ MOHAMMAD KASHIF;
EJAZ, SYEDA TEHMINA

Publication type:

Article

2

Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of Curcuma longa as Potential Lead Inhibitors of ERBB and VEGFR-2 for the Treatment of Colorectal Cancer.

Published in:

Molecules, 2023, v. 28, n. 10, p. 4044, doi. 10.3390/molecules28104044

By:

Ejaz, Syeda Abida;
Aziz, Mubashir;
Fawzy Ramadan, Mohamed;
Fayyaz, Ammara;
Bilal, Muhammad Sajjad

Publication type:

Article

3

Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation, in silico studies, molecular docking, molecular dynamics simulations, and ADMET profiling.

Published in:

Journal of Biomolecular Structure & Dynamics, 2023, v. 41, n. 21, p. 11987, doi. 10.1080/07391102.2022.2164357

By:

Bimoussa, Abdoullah;
Fawzi, Mourad;
Oubella, Ali;
Ejaz, Syeda Abida;
Sajjad Bilal, Muhammad;
Labd Taha, Mohamed;
Auhmani, Aziz;
Morjani, Hamid;
Robert, Anthony;
Riahi, Abdelkhalek;
Ait Itto, My Youssef

Publication type:

Article

4

In Silico Prospects and Therapeutic Applications of Ouabagenin and Hydroxylated Corticosteroid Analogues in the Treatment of Lung Cancer.

Published in:

Applied Biochemistry & Biotechnology, 2022, v. 194, n. 12, p. 6106, doi. 10.1007/s12010-022-04083-4

By:

Ejaz, Syeda Abida;
Aziz, Mubashir;
Birmani, Pervez Rashid;
Alsfouk, Bshra A.;
Alharbi, F. F.;
Bilal, Muhammad Sajjad;
Hassan, Sidra;
Umar, Haruna Isiyaku;
Elhadi, Muawya

Publication type:

Article

5

Computational Exploration of Fluorocyclopentenyl‐purines and‐pyrimidines Derivatives as Potential Inhibitors of Epidermal Growth Factor Receptor (EGFR) for the Treatment of Breast Cancer.

Published in:

Chemistry & Biodiversity, 2023, v. 20, n. 12, p. 1, doi. 10.1002/cbdv.202301190

By:

Abida Ejaz, Syeda;
Sajjad Bilal, Muhammad;
Aziz, Mubashir;
Wani, Tanveer A.;
Zargar, Seema;
Fayyaz, Ammara;
Hassan, Sidra;
Ahmed, Aftab;
Al Kahtani, Hammad M.;
Siddique, Farhan

Publication type:

Article

6

Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.

Published in:

Biomolecules (2218-273X), 2022, v. 12, n. 11, p. 1612, doi. 10.3390/biom12111612

By:

Bilal, Muhammad Sajjad;
Ejaz, Syeda Abida;
Zargar, Seema;
Akhtar, Naveed;
Wani, Tanveer A.;
Riaz, Naheed;
Aborode, Adullahi Tunde;
Siddique, Farhan;
Altwaijry, Nojood;
Alkahtani, Hamad M.;
Umar, Haruna Isiyaku

Publication type:

Article